Search research articles
Contact Us
Filters
Showing results (91-100 of 102) with videos related to
Page
of 11
Sort By:
The Journal of Clinical Psychiatry
|
August 10, 2007
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study
James H Kocsis, Michael E Thase, Madhukar H Trivedi, et al.
Brain Stimulation
|
November 6, 2012
Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects
Scott T Aaronson, Linda L Carpenter, Charles R Conway, et al.
Biological Psychiatry
|
September 11, 2007
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases
Martin B Keller, Madhukar H Trivedi, Michael E Thase, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 4, 2004
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients
A John Rush, Madhukar H Trivedi, Thomas J Carmody, et al.
The Journal of Clinical Psychiatry
|
September 15, 2007
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases
Martin B Keller, Madhukar H Trivedi, Michael E Thase, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)
|
May 7, 2019
The symptom-specific efficacy of antidepressant medication vs. cognitive behavioral therapy in the treatment of depression: results from an individual patient data meta-analysis
Lynn Boschloo, Ella Bekhuis, Erica S Weitz, et al.
Brain Stimulation
|
April 4, 2024
Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report
Charles R Conway, Scott T Aaronson, Harold A Sackeim, et al.
Brain Stimulation
|
December 19, 2024
Effects of vagus nerve stimulation on daily function and quality of life in markedly treatment-resistant major depression: Findings from a one-year, randomized, sham-controlled trial
A John Rush, Charles R Conway, Scott T Aaronson, et al.
Brain Stimulation
|
December 20, 2024
Vagus nerve stimulation in treatment-resistant depression: A one-year, randomized, sham-controlled trial
Charles R Conway, Scott T Aaronson, Harold A Sackeim, et al.
The International Journal of Neuropsychopharmacology
|
January 13, 2026
Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial report
Charles R Conway, Augustus John Rush, Scott T Aaronson, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 102) with videos related to
Sort By:
Page
of 11
The Journal of Clinical Psychiatry
|
August 10, 2007
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study
James H Kocsis, Michael E Thase, Madhukar H Trivedi, et al.
Brain Stimulation
|
November 6, 2012
Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects
Scott T Aaronson, Linda L Carpenter, Charles R Conway, et al.
Biological Psychiatry
|
September 11, 2007
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases
Martin B Keller, Madhukar H Trivedi, Michael E Thase, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 4, 2004
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients
A John Rush, Madhukar H Trivedi, Thomas J Carmody, et al.
The Journal of Clinical Psychiatry
|
September 15, 2007
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases
Martin B Keller, Madhukar H Trivedi, Michael E Thase, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)
|
May 7, 2019
The symptom-specific efficacy of antidepressant medication vs. cognitive behavioral therapy in the treatment of depression: results from an individual patient data meta-analysis
Lynn Boschloo, Ella Bekhuis, Erica S Weitz, et al.
Brain Stimulation
|
April 4, 2024
Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report
Charles R Conway, Scott T Aaronson, Harold A Sackeim, et al.
Brain Stimulation
|
December 19, 2024
Effects of vagus nerve stimulation on daily function and quality of life in markedly treatment-resistant major depression: Findings from a one-year, randomized, sham-controlled trial
A John Rush, Charles R Conway, Scott T Aaronson, et al.
Brain Stimulation
|
December 20, 2024
Vagus nerve stimulation in treatment-resistant depression: A one-year, randomized, sham-controlled trial
Charles R Conway, Scott T Aaronson, Harold A Sackeim, et al.
The International Journal of Neuropsychopharmacology
|
January 13, 2026
Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial report
Charles R Conway, Augustus John Rush, Scott T Aaronson, et al.
Page
of 11